Send to a Friend Share

Jefferies Maintains a 'Buy' on CME Group (CME); 4Q11 Recap: Revised Capital Policy Signals Cash Flow Strength

February 3, 2012 9:20 AM EST
CME Hot Sheet
Rating Summary:
    7 Buy, 7 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 20 | Down: 11 | New: 38
Jefferies maintains a 'Buy' on CME Group (NASDAQ: CME) price target lowered from $315 to $305.

Jefferies analyst said, "CME reported 4Q11 operating results that were below expectations, reflecting a lower than anticipated RPC. The company raised its quarterly dividend by almost 60% and introduced a new annual variable special dividend policy. The company also guided 2012 expense growth of 2-5% based on volume trends, reflecting a greater level of cost flexibility than previously anticipated."

Jefferies lowers FY12 EPS estimate from $18.86 to $17.68. FY12 revs from $3,445.8 mln to $3,313.2 mln.

For an analyst ratings summary and ratings history on CME Group click here. For more ratings news on CME Group click here.

Shares of CME Group closed at $266.01 yesterday, with a 52 week range of $224.69-$317.27.


Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!

You May Also Be Interested In


Related Categories

Analyst Comments

Related Entities

Jefferies & Co, Dividend

Add Your Comment





Follow StreetInsider.com On Twitter